Ashfield Acquires Research Partnership
Healthcare market research and insights company will become part of Ashfield Advisory.
Research Partnership (London, UK), a global healthcare market research and insights company, has been acquired by Ashfield. The company will become part of Ashfield’s advisory and consulting division, Ashfield Advisory.
Working with clients in the pharmaceutical, biotech, consumer healthcare and med tech industries, Research Partnership provides research intelligence on a global basis and throughout the entire lifecycle of products.
Colin Stanley, Global President of Ashfield Advisory, commented: “The addition of the Research Partnership team will bring a new market research and insights capabilities to our services and allows us to further diversify our geographic reach adding capacity in Asia and an increased footprint in Europe.”
Founded in 1997, Research Partnership is headquartered in London with offices in New York, Philadelphia, San Francisco, Lyon, and Singapore. It employs 220+ healthcare experts across the globe, completing projects in over 80 different therapeutic areas.
Newron, Myung In Pharm Form Partnership Centered Around Treating Schizophrenia in South Korea
January 14th 2025The license agreement will feature an upcoming Phase III trial and—depending on results—the development, manufacturing, and commercialization of evenamide as a potential treatment option.
Machine Health in Pharmaceutical Production
December 2nd 2024Predictive maintenance in pharmaceutical production can help reduce downtime and increase efficiency. Grundfos Machine Health (GMH) uses artificial intelligence (AI)-driven wireless sensors to monitor motor health in real-time, identifying potential issues. This approach not only reduces maintenance costs but also ensures compliance with industry standards.
